BCI Marketplace
Transcranial Magnetic Stimulation trials

Mechanisms Of Orbitofrontal Stimulation in Depression

RecruitingNCT07230990Phase: NAStarted 2026-04-15

Summary

The orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improve depressive symptoms. TMS uses magnetic fields generated by a coil placed next to the scalp to alter brain activity.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Inclusion Criteria: * Age 18-65 years * Must be able to read, speak and understand English * DSM-5 diagnosis of major depressive disorder, experiencing a moderate to severe depressive episode (Hamilton Depression Rating Scale score greater than or equal to 17 points) * Must be judged by study staff

Locations

Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →